Form D · Other
Insight Pharmaceuticals Corp
Langhorne, PA · CIK 0001467468
Offering snapshot reported Aug 29, 2011 · SEC filing
- Reported sold
- $65M Offering amount: $65M
- Investors reported
- 10 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Aug 12, 2011 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 29, 2011 | Initial | $65,000,053 | No comparison | 10 | SEC filing |
| Mar 14, 2011 | Initial | $5,600,000 | No comparison | 6 | SEC filing |
| Jul 1, 2009 | Initial | $32,300,000 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Equity, Debt
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-165074
Source: Form D, filed Aug 29, 2011. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| James Berwick | Executive |
| Kipp De Veer | Director |
| Gary Downing | Director, Executive |
| Scott Emerson | Director |
| Craig Hille | Director |
| Dennis Kinsey | Executive |
| Robert Monk | Director |
| Mark Poff | Director, Executive |
| Daniel C. Reese | Director, Executive |
| Michael Smith | Director |
| C. Morris Stout | Director, Executive |
| Joseph Suprenuk | Executive |
| Mickael Tukdarian | Director, Executive |
| Michael Westhusing | Director |
Issuer details
Industry: Other (See others in industry)
Address:
1170 Wheeler Way, Suite 150
Langhorne, PA, 19047
Langhorne, PA, 19047